These sessions were presented as part of the Allied Professionals Forum at HRS Scientific Sessions 2019.  The Allied Professional Forum promotes quality education and inspire attendees to expand scientific discovery to apply it to their daily practice.

For information on registering for the 2020 Allied Professionals Forum and other sessions at #HRS2020, please click here.  

Part I
This session will review commonly seen and sometimes difficult to manage patients with syncope, wide complex tachycardia, and autonomic dysfunction. It will review ECG patterns that have been associated with increased risk for SCD. It will also give an update on best practices for remote monitoring.

Learning Objectives:
To describe the step by step approach to evaluating a patient with syncope
To review key factors in differentiating wide complex tachycardias
To discuss treatment options for patients with autonomic dysfunction
To discuss important factors in optimizing remote monitoring
Presentations:
Chair:  Erica S.. Zado, PAC, FHRS, Hospital of the Univ of Pennsylvania, EP, Philadelphia, PA
Chair: Jill L. Schaeffer, MSN, CRNP, FHRS, CEPS, CCDS, The Heart Group of Lancaster General Health/ Penn Medicine, Stevens, PA

Approaching the Patient with Syncope
James Armstrong, PAC, St. Elizabeth`s Medical Center, Boston, MA
Wide Complex Tachycardia: Differentiating VT from SVT with Aberration
Jose A. Joglar, MD, FHRS, UT Southwestern Med. Ctr. Dallas, Dallas, TX
Remote Monitoring: Best Practice
Stacy M. Poe, MS, MSN, ANP, Cleveland Clinic, Strongsville, OH
ECGs & SCD Risk: Patterns That You Need to Recognize
Stephanie Toth, ACNP, Bryn Mawr Hospital, Glen Mills, PA
Autonomic Dysfunction: Treating the Refractory Patient
Jill L. Schaeffer, MSN, CRNP, FHRS, CEPS, CCDS, The Heart Group, Stevens, PA

Part II
This session will give a review of the current EP guidelines and consensus statements as well as discuss any updates in EP pharmacologic treatments. It will also review how to streamline and transition care of AF patients from inpatient to outpatient to optimize outcomes.

Learning Objectives:
To have an overview of the current EP guidelines and consensus statements
To review updates in EP pharmacology
To identify optimal management for patients with atrial fibrillation
To discuss how to streamline inpatient and outpatient care for patients with AF

Presentations 
Chair: Laurel Kay Racenet, MSN, FNP, FHRS, CEPS, CCDS, Alaska Heart and Vascular Inst, Anchorage, AK
Chair:  Erica S.. Zado, PAC, FHRS, Hospital of the University of Pennsylvania, EP, Philadelphia, PA

2019 EP Guideline and Consensus Update
Christopher X. Wong, MBBS, MPH, MS, PhD, University of Adelaide and Royal Adelaide Hospital, Adelaide, Australia
2019 EP Pharmacologic Update
Kristen B. Campbell, PharmD,. Duke University Hospital, Pharmacy, Durham, NC
AF Management: Streamlining Care to Optimize Outcomes
Jill L. Schaeffer, MSN, CRNP, FHRS, CEPS, CCDS, The Heart Group of Lancaster General Health/ Penn Medicine, Stevens, PA

Part III
This session will touch base on the basics of genetic testing for EP advanced practitioners including patient selection, test choice and interpretation. It will review the approach to EP patients regarding follow up care and restrictions. This session will help the provider to become comfortable approaching end of life discussions regarding device therapy and planning. It will also review the importance of device diagnostics to optimize patient outcomes and management.

Learning Objectives:
To describe the basics of genetic testing including patient selection, test choice and interpretation
To learn ways to approach patients with cardiac devices near their end of life
To review appropriate follow up care and restrictions for patients with arrhythmias and cardiac devices
To learn how to use device diagnostics to optimize patient outcomes

Presentations:
Chair:  Gerilynn M.. Schott, ACNP,  Stanford Healthcare, San Francisco, CA
Chair:  Lindsay Harris, MSN, APRN,  Brigham and Women`s Hospital, Brookline, MA

Genetics for the EP Provider: Who, What Test and How to Interpret
Benjamin Helm, MS. Indiana University School of Medicine/Department Medical and Molecular Genetics, Indianapolis, IN
Device Management During End of Life: How to Start the Discussion
John M. Mandrola, MD,  Louisville Cardiology, Louisville, KY
EP Patient Restrictions: What's Necessary and What's Not
Aileen M. Ferrick, PhD, ACNP, RN, FHRS Westchester Medical Center- El, Larchmont, NY
Device Diagnostics: Tools to Optimize Patient Outcomes
Laurel Kay. Racenet, MSN, FNP, FHRS, CEPS, CCDS, Alaska Heart and Vascular Inst, Anchorage, AK

Nurse Practitioner
Physician’s Assistant
Nurse

A CME Certificate (for physicians) or Certificate of Participation (for non-physicians) will be provided to individuals seeking credit from the following organizations which accept AMA PRA Category 1 Credit(s)™ or have identified credit awarded by ACCME accredited providers as being “substantially equivalent” to their own. Note that participants are advised to contact their certifying body for specific information regarding credit submissions:

· American Academy of Family Practice (AAFP) for elective credit

· American Academy of Nurse Practitioners Certification Board (AANPCB)

· American Academy of Physician Assistants (AAPA)

· American Nurses Credentialing Center (ANCC)

· American Osteopathic Association (AOA) for Category 2 credit

· Committee on Accreditation of Continuing Medical Education  (Canada) 

· European Board of Accreditation in Cardiology (EBAC)

· European CME Credits (ECMEC)

· German Chambers of Physicians

· Oman Medical Specialty Board 

· Qatar Council for Health Practitioners 

· Royal College of Physicians and Surgeons of Canada 

DISCLOSURE POLICY
The Heart Rhythm Society is committed to the provision of Continuing Medical Education (CME) that is balanced, objective, and evidence-based. The Heart Rhythm Society adheres to the Standards for Commercial Support (SCS) of the Accreditation Council for Continuing Medical Education (ACCME) which requires that those individuals in a position to control the content of an educational activity (including planners, faculty, authors, committee members, content reviewers, editors, and staff) disclose all relevant financial relationships (for self and for spouse/partner) with an ACCME-defined commercial interest within the 12 months prior to the disclosure.

VALIDATION

Heart Rhythm Society takes steps to assure its learners and the public that the content of certified activities is accurate and reliable. The following principles are applied to the process of validating CME content. The content is peer-reviewed to ensure the following:

• Fair Balance - that content is balanced among various options available for treatment and not biased toward a particular product or manufacturer.
• Patient Treatment Recommendations - that patient treatment recommendations contained in the content are evidence-based, are appropriate for the target audience, and that the patient treatment recommendations contribute to overall improvement in patient care.
• Scientific Validity - that scientific studies cited in the activity conform to standards accepted by the scientific community.
• Learning Objectives - that the educational content supports the learning objectives of the activity, and that the objectives stated for performance-in-practice are actionable and measurable.
• Omission and Commission - are there any studies, data, or best evidence that is missing?

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn up to 4.25 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

Disclosures:

E.S. Zado: Nothing relevant to disclose.
J.L. Schaeffer:  Honoraria/Speaking/Consulting Fee - Abbott Laboratories.
J. Armstrong: Nothing relevant to disclose.
J.A. Joglar: Nothing relevant to disclose.
S.M. Poe:   Nothing relevant to disclose.
S. Toth: Nothing relevant to disclose.
J.L. Schaeffer:Honoraria/Speaking/Consulting Fee - Abbott Laboratories.
L.K. Racenet: Nothing relevant to disclose.
C.X. Wong:  Nothing relevant to disclose.
K.B. Campbell: Nothing relevant to disclose.
G.M. Schott:   Nothing relevant to disclose.
L. Harris: Nothing relevant to disclose.
B. Helm: Nothing relevant to disclose.
J.M. Mandrola: Nothing relevant to disclose.
A.M. Ferrick: Nothing relevant to disclose.
L.K. Racenet: Nothing relevant to disclose.